SOURCE: THC BioMed Intl Ltd.

THC Biomed Intl Ltd.

May 24, 2016 08:00 ET

Health Canada Grants THC BioMed Oil Production License

THC BioMed Successfully Imports 28 Dutch Cannabis Strains

VANCOUVER, BC --(Marketwired - May 24, 2016) - THC BioMed Intl. Ltd. (CSE: THC) (OTC PINK: THCBF) (FRANKFURT: TFHC) is pleased to announce that our wholly-owned subsidiary, THC BioMed Ltd. has been granted authorization by Health Canada to produce fresh marijuana, Cannabis Oil and Cannabis Resin.

This license allows us to formulate, prepare and present our products. Team THC will work diligently to bring the highest quality products to market within the shortest time frame possible. Products can only be released for sale once Health Canada has granted a sale amendment to its License.

"We now look forward to providing the highest quality products to our customers and bringing value to our shareholders as we work to build a world class Cannabis Company," said John Miller President and CEO. THC BioMed will immediately begin development of a wide range of products including Medical grade Dried cannabis, CBD, THC Oils and Cannabis infused products for topical application.

THC BioMed Ltd. is also pleased to announce it has reached another milestone, by setting the foundation of another subsidiary, Seeds R Us, focused on establishing a national supply chain for Cannabis genetics. We are now in possession of a diverse selection of seeds, imported from Holland. The imported genetics are listed on our THC BioMed.com website under the Seeds R Us tab and include high CBD and high THC producing strains. Profiling for both genotypes and phenotypes, for each of the 28 strains is currently underway.

THC's Vision is to be on the leading edge of scientific research and development of products and services related to the medical cannabis industry. Management feels that THC is well positioned to be in the forefront of this rapidly growing industry where our high standard of excellence and our commitment to scientific research and new product and service development.

Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC. Forward-looking information is based on certain key expectations and assumptions made by the management of THC. Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Contact Information